Ming Xian - Jun 3, 2021 Form 4 Insider Report for MEDIFAST INC (MED)

Role: Director
Signature: /s/ Jason L. Groves, attorney-in-fact
Stock symbol: MED
Transactions as of: Jun 3, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/7/2021, 08:41 PM
Next filing: Jun 21, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MED	Restricted Stock Units (cash settled)	Award	$0	+630	+29.7%	$0.00	2.75K	Jun 3, 2021	Common Stock	630		Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.

Content

Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.